Eargo, Inc. files for IPO.

The IPO of Eargo, Inc. (EAR) will take place on October 15, 2020. Eargo is a manufacturer of the medical devices that help to improve the quality of life for people with hearing loss. Hearing loss is a natural consequence of aging and has a significant impact on the quality of life. Hearing loss is one of the most common health conditions and the third most common condition in the United States – more common that diabetes and cancer. Eargo hearing aids are considered to be the first and only virtually invisible, rechargeable, completely-in-canal device for the treatment of hearing loss.
 
The company’s estimated value after its IPO will be $542.1 million. The IPO listed bookrunners are J.P. Morgan, BofA Securities, Wells Fargo Securities and William Blair.